# METATENSIN #2
> **NDA012972** · New Drug Application · Sponsor: SANOFI AVENTIS US
## Drug
- **FDA Application Number:** NDA012972
- **Application type:** New Drug Application
- **Brand name:** METATENSIN #2
- **Generic name:** Reserpine
- **Active ingredients:** RESERPINE; TRICHLORMETHIAZIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SANOFI AVENTIS US
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012972)
---
*MORVS · CC0 1.0*